Document Detail

PHARMAC and Ventolin in New Zealand.
MedLine Citation:
PMID:  16132077     Owner:  NLM     Status:  MEDLINE    
Recently, PHARMAC undertook an unfortunate experiment on asthma sufferers when it fundamentally changed its funding support for reliever medications. Ventolin metered dose inhaler (MDI), the backbone of asthma relief for over 30 years, was dropped in favour of Salamol, a post-patent salbutamol in a device which, within the first few weeks of use, has been found to be ineffective by many patients, and thus potentially dangerous. PHARMAC has agreed to reconsider its decision, but how was this decision reached in the first place?
John Gillies; Jeff Brown; Cass Byrnes; Alan Farrell; David Graham
Related Documents :
20677117 - [dgrw-update: medical rehabilitation with children and adolescents].
2209137 - Characteristics and correlates of asthma in a university clinic population.
11990227 - Influence of sociodemographics on the health-related quality of life of pediatric patie...
16639147 - Inhalants: not to be taken lightly anymore.
20058567 - Daytime sleepiness and sleep quality among malaysian medical students.
2270997 - Dr warwick carter, medical writer.
Publication Detail:
Type:  Journal Article     Date:  2005-08-12
Journal Detail:
Title:  The New Zealand medical journal     Volume:  118     ISSN:  1175-8716     ISO Abbreviation:  N. Z. Med. J.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-31     Completed Date:  2005-11-30     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0401067     Medline TA:  N Z Med J     Country:  New Zealand    
Other Details:
Languages:  eng     Pagination:  U1616     Citation Subset:  IM    
Anglesea Paediatrics Ltd, Hamilton, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Albuterol / administration & dosage*
Asthma / drug therapy*
Bronchodilator Agents / administration & dosage*
Drug Industry / methods*
Equipment Design
Equipment Failure
Metered Dose Inhalers
New Zealand
Treatment Outcome
Reg. No./Substance:
0/Bronchodilator Agents; 18559-94-9/Albuterol
Comment In:
N Z Med J. 2005 Aug 26;118(1221):U1644   [PMID:  16138178 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Coeliac disease diagnosed at Starship Children's Hospital: 1999-2002.
Next Document:  Comparative and evolutionary analysis of the bacterial homologous recombination systems.